up home page bottom

French German version Spanish version Italian version

header image

Kansas teen wants Gardasil taken off the market

As Reported on KVUE News, Sunday February 15, 2009… It was a hot issue here in Texas a couple of years ago.  Now Gardasil, the vaccine against the virus that causes cervical caner, is back in the spotlight. Gabi Swank, a 16-year-old from Wichita, Kansas, says she and other girls are dying from the side-effects [...]

Share

NVIC Says Government Denies Gardasil Risks

Vaccine Watchdog Group Calls for Transparency WASHINGTON–(BUSINESS WIRE)–The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal investigators involved in a statement this week maintaining that Gardasil vaccine is safe with no serious [...]

Share

More Questions About Gardasil®

A Recent CNN Article lead with this headline… Gardasil® Deaths, Gardasil® Side Effects, Gardasil® Paralysis – Is the HPV Vaccine Given to Prevent Cervical Cancer Causing More Medical Problems? A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems. Gardasil® has [...]

Share

FDA Addresses Questions About Gardasil®

Those of you who are regular readers know that I think Gardasil® is the wrong solution for preventing Cervical Cancer. It is my considered opinion that Gardasil® has one purpose — it is a much needed cash cow for Merck, in their time of financial need.  My attempt at “Fair and Balanced” reporting is to [...]

Share

More About PAP SMEAR Option

From: Chartbook on Trends in the Health of Americans Health, United States, 2005 Pap Smear A Pap smear is a microscopic examination of cells scraped from the cervix that is used to detect cancerous or precancerous conditions of the cervix and other medical conditions. If detected, precancerous conditions can be treated before they become malignant. [...]

Share

Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market

The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world’s second-largest drugmaker, requested a ‘priority’ review, potentially prompting an approval decision and sale of the Cervarix vaccine by the end of 2007, said James Tursi, Glaxo’s director of medical affairs for cervical cancer vaccines, at a medical meeting in San Diego.

Share
Private